Abstract
| Original language | English |
|---|---|
| Pages (from-to) | 2494-2508 |
| Number of pages | 15 |
| Journal | Molecular Pharmaceutics |
| Volume | 22 |
| Issue number | 5 |
| Early online date | 9 Apr 2025 |
| DOIs | |
| Publication status | Published - 5 May 2025 |
Bibliographical note
Publisher Copyright:© 2025 The Authors. Published by American Chemical Society.
Funding
B.W. was supported by U.K. Research and Innovation (UKRI), grant reference number EP/S023437/1. This study was also supported by Grants PID2021-126014OB-I00 and PID2021-122212OA-I00 funded by the MCIU/AEI/10.13039/501100011033/FEDER, UE, and by the Grant IT1449-22 funded by the Basque Government. S.I. acknowledges a research contract from the University of the Basque Country (DOCREC21/20). E.R. acknowledges funding by the ERC (grant H2020-MSCA-COFUND-2020-101034228-WOLFRAM2). C.D. acknowledges PRACE for awarding access to computational resources in CSCS, the Swiss National Supercomputing Service, in two of their Project Access Calls. This project also made use of computing time on UK Tier 2 JADE and Bede, granted via the UK High-End Computing Consortium for Biomolecular Simulation, HECBioSim ( http://hecbiosim.ac.uk ), supported by EPSRC (grant no. EP/R029407/1) and on the Red Espan\u0303ola de Supercomputacio\u0301n. For the purpose of open access, B.W. has applied a Creative Commons Attribution (CC BY) license to any Author Accepted Manuscript version that arises.
| Funders | Funder number |
|---|---|
| Eusko Jaurlaritza | |
| Euskal Herriko Unibertsitatea | DOCREC21/20 |
| UK Research & Innovation | IT1449-22, PID2021-122212OA-I00, EP/S023437/1, PID2021-126014OB-I00 |
| Engineering and Physical Sciences Research Council | EP/R029407/1 |
| European Research Council | H2020-MSCA-COFUND-2020-101034228-WOLFRAM2 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- HIV-1 neutralization mechanism
- MD simulations
- MPER antibody
- antibody engineering
- antibody-membrane interaction
- site-selective chemical modification
- therapeutic antibody
ASJC Scopus subject areas
- Molecular Medicine
- Pharmaceutical Science
- Drug Discovery
Fingerprint
Dive into the research topics of 'Distinctive Membrane Accommodation Traits Underpinning the Neutralization Activity of HIV-1 Antibody against MPER'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS